PYRIDOPYRIMIDINES AS HISTAMINE-H4 RECEPTOR INHIBITORS
CY1125644T1Undetermined Publication Date: 2026-04-17FAES FARMA SA
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20221100708T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-07-25
- Filing Date
- 2022-11-01
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2042-11-01
Abstract
The invention relates to compounds of chemical formula (1) or pharmaceutically acceptable salts or solvates thereof, to pharmaceutical compositions containing them and to their use in the treatment and / or prevention of diseases or disorders mediated by the histamine-H4 receptor.
Need to check novelty before this filing date? Find Prior Art